Pfizer Overview
- Year Founded
-
1848
- Status
-
Public
- Employees
-
75,000
- Stock Symbol
-
PFE
- Investments
-
163
- Share Price
-
$28.89
- (As of Friday Closing)
Pfizer General Information
Description
Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13 and cardiology drugs Vyndamax and Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.
Contact Information
Website
www.pfizer.comCorporate Office
- 66 Hudson Boulevard East
- New York, NY 10001-2192
- United States
Corporate Office
- 66 Hudson Boulevard East
- New York, NY 10001-2192
- United States
Pfizer Timeline
Pfizer Stock Performance
As of 13-Nov-2026, Pfizer’s stock price is $28.89. Its current market cap is $165B with 5.7B shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $28.89 | $28.83 | $23.62 - $31.44 | $165B | 5.7B | 33.4M | $0.71 |
Pfizer Financials Summary
As of 30-Sep-2026, Pfizer has a trailing 12-month revenue of $63.6B.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 214,352,691 | 187,733,118 | 207,282,246 | 181,568,239 |
| Revenue | 63,625,000 | 62,579,000 | 63,627,000 | 59,554,000 |
| EBITDA | 12,966,000 | 16,180,000 | 17,582,000 | 7,933,000 |
| Net Income | 4,033,000 | 7,771,000 | 8,031,000 | 2,119,000 |
| Total Assets | 204,544,000 | 208,160,000 | 213,396,000 | 226,501,000 |
| Total Debt | 62,671,000 | 63,961,000 | 63,649,000 | 70,845,000 |
Pfizer Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Pfizer Comparisons
Industry
Financing
Details
Pfizer Competitors (20)
One of Pfizer’s 20 competitors is Merck & Co., a Corporation company based in Rahway, NJ.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Merck & Co. | Corporation | Rahway, NJ | ||||
| GSK | Corporation | London, United Kingdom | ||||
| Johnson & Johnson | Corporation | New Brunswick, NJ | ||||
| AbbVie | Corporation | North Chicago, IL | ||||
| AstraZeneca | Formerly PE-Backed | Cambridge, United Kingdom |
Pfizer Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
News about Pfizer
Dive into recent articles by PitchBook offering invaluable insights and context.
Pfizer Patents
Pfizer Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026229857-A1 | Method of forming multi-specific antibodies from homodimer antibodies and pharmaceutical product including multi-specific antibodies thus obtained | Pending | 30-Apr-2025 | ||
| WO-2026229854-A1 | Vaccines against respiratory diseases | Pending | 30-Apr-2025 | ||
| US-20260345786-A1 | Novel nitrogen-containing heterocyclic compounds | Pending | 11-Apr-2025 | ||
| WO-2026215853-A1 | Novel nitrogen-containing heterocyclic compounds | Pending | 11-Apr-2025 | ||
| WO-2026215858-A1 | Novel nitrogen-containing heterocyclic compounds | Pending | 11-Apr-2025 | C07D471/04 |
Pfizer Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Pfizer Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Pfizer Investments & Acquisitions (163)
Pfizer’s most recent deal was a Later Stage VC with Engine Biosciences for . The deal was made on 05-Aug-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Engine Biosciences | 05-Aug-2026 | Later Stage VC | Drug Discovery | ||
| Anthriq | 01-Jun-2026 | Accelerator/Incubator | Enterprise Systems (Healthcare) | ||
| BabyCue | 01-Jun-2026 | Accelerator/Incubator | Diagnostic Equipment | ||
| CellCentric | 06-May-2026 | Later Stage VC | Drug Discovery | ||
| Metsera | 13-Nov-2025 | Merger/Acquisition | Drug Discovery |
Pfizer ESG
Risk Overview
Risk Rating
Updated November, 04, 2026
15.64 | Low Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,585
Rank
Percentile
Pharmaceuticals
Industry
of 852
Rank
Percentile
Pharmaceuticals
Subindustry
of 354
Rank
Percentile
Pfizer Exits (60)
Pfizer’s most recent exit was on 30-Jun-2023 from Caribou Biosciences. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Caribou Biosciences | 30-Jun-2023 | Completed |
|
||
| Telavant | 01-Dec-2022 | Completed |
|
||
| Anokion | 18-Oct-2022 | Completed |
|
||
| OMEC.AI | 01-Sep-2022 | Completed |
|
||
| Agomab Therapeutics | 13-Jul-2022 | Later Stage VC | Completed |
|
Pfizer Affiliates
Subsidiaries (20)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Pfizer Saudi | Riyadh, Saudi Arabia | 2017 | |
| Biohaven | New Haven, CT | 2013 | |
| Hospira 401(K) Retirement Savings Plan | Peapack, NJ | 2004 | |
| Pfizer Ventures | New York, NY | 2004 | |
| Pfizer Hospital | Lake Forest, IL | 2003 |
Pfizer FAQs
-
When was Pfizer founded?
Pfizer was founded in 1848.
-
Where is Pfizer headquartered?
Pfizer is headquartered in New York, NY.
-
What is the size of Pfizer?
Pfizer has 75,000 total employees.
-
What industry is Pfizer in?
Pfizer’s primary industry is Pharmaceuticals.
-
Is Pfizer a private or public company?
Pfizer is a Public company.
-
What is Pfizer’s stock symbol?
The ticker symbol for Pfizer is PFE.
-
What is the current stock price of Pfizer?
As of 13-Nov-2026 the stock price of Pfizer is $28.89.
-
What is the current market cap of Pfizer?
The current market capitalization of Pfizer is $165B.
-
What is Pfizer’s current revenue?
The trailing twelve month revenue for Pfizer is $63.6B.
-
Who are Pfizer’s competitors?
Merck & Co., GSK, Johnson & Johnson, AbbVie, and AstraZeneca are some of the 20 competitors of Pfizer.
-
What is Pfizer’s annual earnings per share (EPS)?
Pfizer’s EPS for 12 months was $0.71.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
